URS
CRL icon

Utah Retirement Systems’s Charles River Laboratories CRL Stock Holding History

Utah Retirement Systems’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$585K Hold
2,579
– – 0.01% 749
2026
Q1 		$445K Sell
2,579
-5,472
-68% -$1.01M ﹤0.01% 747
2025
Q4 		$1.61M Hold
8,051
– – 0.02% 623
2025
Q3 		$1.26M Sell
8,051
-207
-3% -$32.9K 0.01% 665
2025
Q2 		$1.25M Sell
8,258
-137
-2% -$18.3K 0.01% 665
2025
Q1 		$1.26M Hold
8,395
– – 0.01% 665
2024
Q4 		$1.55M Hold
8,395
– – 0.02% 622
2024
Q3 		$1.65M Hold
8,395
– – 0.02% 611
2024
Q2 		$1.73M Sell
8,395
-400
-5% -$90.6K 0.02% 575
2024
Q1 		$2.38M Hold
8,795
– – 0.03% 517
2023
Q4 		$2.08M Buy
8,795
+100
+1% +$19.7K 0.03% 538
2023
Q3 		$1.7M Hold
8,695
– – 0.02% 570
2023
Q2 		$1.83M Sell
8,695
-300
-3% -$59.7K 0.03% 553
2023
Q1 		$1.82M Hold
8,995
– – 0.03% 561
2022
Q4 		$1.96M Sell
8,995
-100
-1% -$21.8K 0.03% 496
2022
Q3 		$1.79M Buy
9,095
+200
+2% +$43.2K 0.03% 516
2022
Q2 		$1.9M Hold
8,895
– – 0.03% 507
2022
Q1 		$2.53M Sell
8,895
-100
-1% -$30.8K 0.03% 482
2021
Q4 		$3.39M Buy
8,995
+43
+0.5% +$16.7K 0.04% 416
2021
Q3 		$3.69M Sell
8,952
-500
-5% -$208K 0.05% 378
2021
Q2 		$3.5M Buy
9,452
+37
+0.4% +$12.4K 0.05% 410
2021
Q1 		$2.73M Sell
9,415
-364
-4% -$101K 0.04% 460
2020
Q4 		$2.44M Buy
9,779
+400
+4% +$95.3K 0.03% 480
2020
Q3 		$2.12M Buy
9,379
+100
+1% +$20.8K 0.04% 460
2020
Q2 		$1.62M Buy
9,279
+100
+1% +$16K 0.03% 501
2020
Q1 		$1.16M Hold
9,179
– – 0.03% 547
2019
Q4 		$1.4M Buy
9,179
+100
+1% +$13.8K 0.02% 616
2019
Q3 		$1.2M Hold
9,079
– – 0.02% 656
2019
Q2 		$1.29M Buy
9,079
+170
+2% +$23.1K 0.02% 631
2019
Q1 		$1.29M Buy
8,909
+112
+1% +$14.7K 0.03% 617
2018
Q4 		$995K Hold
8,797
– – 0.02% 650
2018
Q3 		$1.18M Hold
8,797
– – 0.02% 653
2018
Q2 		$988K Hold
8,797
– – 0.02% 736
2018
Q1 		$939K Hold
8,797
– – 0.02% 727
2017
Q4 		$963K Buy
8,797
+200
+2% +$21.8K 0.02% 725
2017
Q3 		$928K Hold
8,597
– – 0.02% 708
2017
Q2 		$869K Hold
8,597
– – 0.02% 739
2017
Q1 		$773K Buy
8,597
+100
+1% +$8.49K 0.02% 753
2016
Q4 		$647K Sell
8,497
-100
-1% -$7.59K 0.02% 800
2016
Q3 		$716K Hold
8,597
– – 0.02% 757
2016
Q2 		$709K Buy
8,597
+100
+1% +$8.24K 0.02% 749
2016
Q1 		$646K Hold
8,497
– – 0.02% 747
2015
Q4 		$683K Buy
8,497
+100
+1% +$7.21K 0.02% 747
2015
Q3 		$533K Hold
8,397
– – 0.02% 841
2015
Q2 		$591K Sell
8,397
-300
-3% -$22.2K 0.02% 861
2015
Q1 		$690K Buy
8,697
+400
+5% +$29.5K 0.02% 791
2014
Q4 		$528K Hold
8,297
– – 0.01% 869
2014
Q3 		$496K Hold
8,297
– – 0.01% 886
2014
Q2 		$444K Sell
8,297
-500
-6% -$27.4K 0.01% 944
2014
Q1 		$531K Buy
8,797
+100
+1% +$5.83K 0.02% 852
2013
Q4 		$462K Hold
8,697
– – 0.01% 884
2013
Q3 		$402K Sell
8,697
-100
-1% -$4.59K 0.01% 902
2013
Q2 		$361K Buy
+8,797
New +$377K 0.01% 918

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Utah Retirement Systems's CRL Position: Q2 2026 in Review

Utah Retirement Systems held its Charles River Laboratories (CRL) position steady in Q2 2026 at 2,579 shares worth $585K. The position accounts for 0.01% of the portfolio, ranked #749.

Utah Retirement Systems first reported a position in CRL in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.69M in Q3 2021. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Utah Retirement Systems held 2,579 shares of Charles River Laboratories worth $585K as of Q2 2026.
  • Utah Retirement Systems left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up 0.01% of Utah Retirement Systems's portfolio in Q2 2026, its #749 holding.
  • Utah Retirement Systems first reported a position in Charles River Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Utah Retirement Systems's Charles River Laboratories position peaked at $3.69M in Q3 2021.
  • 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Utah Retirement Systems's 13F filing for Q2 2026, filed 14 Aug 2026.